Osteopore Limited (ASX:OSX)

Market Cap	2.39M
Revenue (ttm)	2.76M
Net Income (ttm)	-3.35M
Shares Out	140.35M
EPS (ttm)	-0.04
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,436,104
Average Volume	8,630,607
Open	0.0170
Previous Close	0.0170
Day's Range	0.0150 - 0.0170
52-Week Range	0.0120 - 0.4000
Beta	-0.06
RSI	38.66
Earnings Date	May 30, 2025

About Osteopore

Osteopore Limited, a regenerative medicine company, engages in the production of 3D-printed biomimetic and bioresorbable implants in Vietnam, South Korea, the Philippines, Singapore, the United States, Malaysia, Indonesia, Netherlands, South Africa, Thailand, and internationally. The company commercializes a range of bespoke products to facilitate bone healing across multiple therapeutic areas. Its technology fabricates specific micro-structured scaffolds for bone regeneration through 3D printing and bioresorbable material. It manufactures and ...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2018
• Country: Australia
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: OSX

Financial Performance

In 2024, Osteopore's revenue was 2.76 million, an increase of 24.60% compared to the previous year's 2.22 million. Losses were -3.35 million, -31.19% less than in 2023.